5. Which pharmacotherapy has been shown to delay the need for aortic valve replacement in the setting of severe aortic valve regurgitation?

A. Nondihydropyridine calcium channel blockers

B. Beta-blockers

C. Angiotensin converting enzyme inhibitors (ACE inhibitors)

D. Hydralazine

E. None of the above

PROCEED TO ANSWER